- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05952466
Retinal and Choroidal Microvascular Parameters in School-age Children in a COVID-19 Infection Pandemic Peak in China
July 18, 2023 updated by: Yuehong Zhang, Guangzhou First People's Hospital
Optical Coherence Tomography Angiography Evaluation of Retinal and Choroidal Microvascular Parameters in School-age Children in a COVID-19 Infection Pandemic Peak in China
We designed this study to examine whether COVID-19 infection could lead to retinal and choroidal microvascular involvement in school-age children (6-18 years) in a pandemic peak in China.
Study Overview
Status
Completed
Conditions
Detailed Description
This is an observational case-control study.
One hundred school-age children who visited the Department of Ophthalmology at Guangzhou First People's Hospital in China from February 1, 2023 to March 31, 2023 were included in this study.
Eighty children with COVID-19 infection were included in the case group.
Controls without COVID-19 infection were matched to COVID-19 infection cases by a ratio of 1:4 using frequency matching on age and gender.
The primary end point of this study is the retinal and choroidal microvascular changes in school-age children during the COVID-19 pandemic.
Secondary endpoint is the
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China
- Guangzhou First People's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Totally 100 school-age children (6-18 years) were enrolled in this study.
All subjects had visited the ophthalmology clinic for routine ocular examinations.Eighty children with COVID-19 infection were included in the case group.
Controls without COVID-19 infection were matched to COVID-19 infection cases by a ratio of 1:4 using frequency matching on age and gender.
The following age subgroups were used for matching: 6-10, 10-14 and 15-18 years.
A list of numbers computer-generated by a research member (Xu Zhang) was used to match the controls.
The collected data included demographic and clinical data, as well as retinal and choroidal microvascular parameters.
Description
Inclusion Criteria:
Totally 100 school-age children (6-18 years) were enrolled in this study. All subjects had visited the ophthalmology clinic for routine ocular examinations. Refraction after ciliary muscle paralysis, myopia ≥ -6.0 spherical diopter, astigmatism ≤ 2.5 cylindrical diopter.
Exclusion Criteria:
- The child or guardian did not agree to participate in the study.
- Children could cooperate to complete the ocular examination.
- The child had previous diseases affecting visual function and fundus, except for the diagnosis of refractive error.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
COVID-19 infection group
School-age children infected recently with COVID-19
|
control group
School-age children without COVID-19
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Macular and peripapillary blood perfusion density
Time Frame: 5 minutes
|
The blood flow density represents the proportion of the blood flow signal area in the scanning area to the overall area, expressed in units of mm-1, which can show the blood vessel perfusion and circulation.
|
5 minutes
|
Macular and peripapillary retinal thickness
Time Frame: 3 minutes
|
Macular fovea and peripheral retinal thickness, retinal thickness around the optic nerve
|
3 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fundus lesions
Time Frame: 2 minutes
|
Such as fundus hemorrhage, exudation, vascular tortuous expansion, etc.
|
2 minutes
|
Vascular distribution shape in macular area
Time Frame: 2 minutes
|
The measurement parameters of the foveal avascular zone include area, perimeter and non-circular index
|
2 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yuehong Zhang, Guangzhou First People's Hospital, Guangzhou, Guangdong China
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2023
Primary Completion (Actual)
March 31, 2023
Study Completion (Actual)
March 31, 2023
Study Registration Dates
First Submitted
July 18, 2023
First Submitted That Met QC Criteria
July 18, 2023
First Posted (Actual)
July 19, 2023
Study Record Updates
Last Update Posted (Actual)
July 19, 2023
Last Update Submitted That Met QC Criteria
July 18, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GuangzhouFPH1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19 Pandemic
-
Laval UniversityCISSS de Chaudière-Appalaches; VITAM: Research Center on Sustainable Health; Centre... and other collaboratorsRecruiting
-
Assiut UniversityDoaa M.EL ShehabyUnknownCovid 19 Pandemic From Ethical View
-
University of JordanAysha Alkhayat; Mariam Aljweesri; Reem Alharbi; Zahraa AljazzafCompleted
-
Sialkott College of Physical TherapyCompletedBurnout, Psychological | Covid-19 PandemicPakistan
-
Charite University, Berlin, GermanyRecruitingAnxiety Related to the COVID-19 PandemicGermany
-
University Hospital, BrestCompletedIdentify Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 PandemicFrance
-
Dr. Soetomo General HospitalIndonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, IndonesiaRecruitingCOVID-19 Pandemic | COVID-19 Vaccines | COVID-19 Virus DiseaseIndonesia
-
Hospices Civils de LyonCompletedEmergency Department Staff During the COVID-19 Pandemic | Emergency Department Staff's Level of StressFrance
-
Dr. Soetomo General HospitalIndonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, IndonesiaRecruitingCOVID-19 Pandemic | COVID-19 VaccinesIndonesia
-
Dr. Soetomo General HospitalIndonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, IndonesiaRecruitingCOVID-19 Pandemic | COVID-19 VaccinesIndonesia